1.. Introduction {#s1}
================

Human African trypanosomiasis (HAT) is a neglected disease caused by subspecies of *Trypanosoma brucei*, which are blood-borne extracellular protozoa transmitted by tsetse fly (*Glossina* ssp). HAT is fatal if untreated. In early HAT, parasites are intravascular (haemolymphatic/Stage I disease) but as infection progresses, parasites cross endothelia and invade extravascular tissue within different organs. When parasites traverse the blood brain barrier (BBB), neuropsychiatric disturbances develop ('sleeping sickness'/Stage II disease). Whilst central nervous system (CNS) involvement is the clinical focus of patient screens, cardiac disturbances are now recognized as significant symptoms in HAT. A recent field study observed high prevalence of cardiac electrical abnormalities in HAT (∼55% of Stage I, ∼70% of Stage II patients).^[@CVT187C1],[@CVT187C2]^ Of note was the increased proportion of HAT patients experiencing palpitations.^[@CVT187C1],[@CVT187C2]^ Other reported cardiac-related abnormalities include conduction block, low voltage abnormalities, ventricular dilatation and heart failure;^[@CVT187C1]--[@CVT187C7]^ 23% of HAT patients have NT-proBNP levels (N-terminal pro b-type natriuretic peptide; a biomarker of excessive cardiomyocyte stretching) consistent with left ventricular dysfunction.^[@CVT187C2]^ Both experimentally infected animals and between 70--100% of human autopsies show clear heart pathology including pancarditis.^[@CVT187C8]--[@CVT187C10]^ Experimental animal models demonstrate significant trypanosome numbers within myocardial interstitium, with or without a mononuclear cellular infiltrate.^[@CVT187C9]^ Despite the large number of studies demonstrating heart involvement in African trypanosomiasis, the appreciation of cardiac dysfunction as a clinical feature, and consequently our understanding of the basic cardiac pathogenesis, is very limited. In contrast, a significant body of recent work has focused on the neuro-pathogenesis of the disease showing that both an inflammatory response and trypanosome interaction with BBB cells are important.^[@CVT187C11],[@CVT187C12]^ Therefore, one inference is that the cardiac-related clinical signs in African trypanosomiasis result from the inflammatory response. Whilst this may indeed play a role, an alternative hypothesis of parasites interacting with cardiomyocytes and altering heart function is untested.

Sarcoplasmic reticulum (SR)-mediated Ca^2+^ release during excitation--contraction coupling causes cardiomyocyte and whole heart contraction (systole). Cardiomyocytes relax (diastole) by lowering intracellular Ca^2+^ concentration (\[Ca^2+^\]~i,~) predominantly by SR-mediated Ca^2+^ uptake via SERCA and sarcolemmal extrusion via the Na^+^/Ca^2+^ exchanger (NCX). Under certain circumstances (e.g. heart failure), SR-mediated Ca^2+^ release can also occur spontaneously without electrical excitation, as propagating Ca^2+^ waves. These events are linked to impaired contraction, abnormal electrical activity, ventricular premature complexes (VPC) (which can cause palpitations), and the triggering of fatal arrhythmias.^[@CVT187C13]^

Previous *in vitro* studies on trypanosome interaction with brain microvascular endothelial cells (BMECs) demonstrated that trypanosomes induce changes in \[Ca^2+^\]~i~ dynamics which correlated with the parasite\'s ability to cross the BMEC monolayer.^[@CVT187C12]^ Given that trypanosomes affect host cell \[Ca^2+^\]~i~ dynamics, and the pivotal role of Ca^2+^ in cardiomyocyte and heart function, the aim of this study was to utilize isolated cardiomyocytes and whole hearts to investigate the hypothesis that African trypanosomes alter intra-cardiomyocyte Ca^2+^ handling and whole heart function.

2.. Methods {#s2}
===========

2.1. Adult cardiomyocyte isolation {#s2a}
----------------------------------

Adult male Wistar rats (200--300 g) were euthanized by schedule one procedure (concussion followed by cervical dislocation) in accordance with the UK Animals (Scientific Procedures) Act 1986, Directive 2010/63/EU of the European Parliament and University of Glasgow ethical review panel. Cardiomyocytes were isolated as previously described^[@CVT187C14]^ (see [Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)). Cardiomyocytes were re-suspended in a Modified Isolation Krebs--Henseleit (MIKH), 1.8 mM \[Ca^2+^\]~o~.

2.2. Preparation of trypanosomes, media, and supernatant {#s2b}
--------------------------------------------------------

Parasites were cultured in HMI-9, 20% v/v Serum Plus® (SAFC Biosciences) (37°C, 5% CO~2~; see [Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)); referred to as live trypanosomes. Parasite number was equivalent to that found during human and livestock infections (∼5.0×10^5^ parasites mL^−1^). Supernatant was prepared by centrifugation of live trypanosome suspension (857 *g*, 10 min) and subsequent removal of supernatant. To ensure no trypanosome contamination, supernatant was filtered (0.2 µm filter, Sartorius Stedim). HMI-9 with 20% v/v Serum Plus® without trypanosomes is referred to as media and was treated identically to supernatant (i.e. centrifuged and filtered).

2.3. Spontaneous contractile event measurements in isolated rat cardiomyocytes {#s2c}
------------------------------------------------------------------------------

Isolated adult cardiomyocytes were incubated for 30 min \[room temperature (RT)\] with live trypanosomes, supernatant, or media and then placed in a cell bath containing the corresponding solution. Cardiomyocytes were viewed under a light microscope and contractile events measured (see [Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)).

2.4. Confocal imaging of spontaneous SR-mediated Ca^2+^ release {#s2d}
---------------------------------------------------------------

Intact cardiomyocytes in MIKH, 1.0 mM \[Ca^2+^\]~o~ were loaded with Ca^2+^-sensitive fluorophore (5.0 μM Fluo-3AM, Biotium;10 min incubation). MIKH was removed and cardiomyocytes re-suspended in media or supernatant for a further 30 min to ensure complete de-esterification. Cardiomyocytes were then perfused with media or supernatant and field stimulated (1.0 Hz, 45 s, RT) to allow for the steady-state SR Ca^2+^ content. Field stimulation was terminated and a 45 s rest period enabled spontaneous Ca^2+^ release event visualization and measurement (see [Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)).

2.5. Epifluorescence measurements of field stimulated Ca^2+^ transients {#s2e}
-----------------------------------------------------------------------

Intact cardiomyocytes (1.0 mM \[Ca^2+^\]~o~) were loaded with Ca^2+^-sensitive fluorophore (5.0 μM Fura-4FAM, Invitrogen). Cardiomyocytes were incubated (30 min) in media or supernatant and allowed to settle in a cell bath (Cell Microcontrols) followed by superfusion with media/supernatant (37°C) and field stimulation (1.0 Hz, 2.0 ms, voltage set to 1.5× threshold). In separate experiments, cardiomyocytes were field stimulated and perfused firstly with media (60 s) and then supernatant (60 s). Caffeine (10 mM, 20 s; without field-stimulation) was applied before the protocol, after perfusion with media and after supernatant. The three caffeine and two solution changes were all performed on the same isolated cardiomyocyte, enabling accurate paired-assessment of the SR Ca^2+^ content between media and supernatant (see [Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)).

2.6. Epifluorescence measurements of diastolic \[Ca^2+^\]~i~ during SR inhibition {#s2f}
---------------------------------------------------------------------------------

Fura-2AM loaded cardiomyocytes were incubated with thapsigargin (1 μM; Merckmillipore) and ryanodine (1 μM; Merck Millipore) for 30 min to inhibit SR function and then perfused with media and/or supernatant for 5 min in the continued presence of inhibitors. Changes in diastolic \[Ca^2+^\]~i~ were then measured (see [Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)).

2.7. RNA interference of *T. brucei* cathepsin-L (TbCatL) {#s2g}
---------------------------------------------------------

TbCatL RNAi (see [Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)) was induced with 1 µg mL^−1^ tetracycline and triplicate growth curves performed for induced/uninduced cultures, initiated with 1.0 × 10^5^ cells mL^−1^ and counted at 24, 48, and 72 h post-induction. Quantitative PCR was performed to measure relative TbCatL gene expression (see [Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)).

2.8. Langendorff perfused rat hearts {#s2h}
------------------------------------

Isolated hearts were cannulated via the aorta, perfused with media or supernatant and pseudo-ECG measurements performed (iworx; see [Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)).

2.9. Statistical analysis {#s2i}
-------------------------

Data expressed as means ± SEM. For Ca^2+^ transient amplitude and Ca^2+^ wave parameters paired Student\'s *t*-test was used, with ANOVA for multiple comparisons. Multiple linear regression analysis was used to compare nominal categorical data with continuous variables. Normal distribution was assessed by plotting of residuals. Differences were considered significant when *P* \< 0.05.

3.. Results {#s3}
===========

3.1. Trypanosomes increase spontaneous contractile events in isolated cardiomyocytes {#s3a}
------------------------------------------------------------------------------------

To investigate whether *Trypanosoma brucei* altered cardiomyocyte function, spontaneous contractile events were quantified. When cardiomyocytes were incubated with live trypanosomes (*Figure [1](#CVT187F1){ref-type="fig"}A*) the cardiomyocyte percentage producing spontaneous contractile events increased to 145% of media levels (52.1 ± 1.6 vs. 75.4 ± 5.3% cardiomyocytes exhibiting at least one spontaneous contractile event min^−1^; media vs. live trypanosomes; *P* \< 0.001; *Figure [1](#CVT187F1){ref-type="fig"}B*). Interestingly, this effect was maintained when cardiomyocytes were incubated with supernatant, which increased spontaneous contractile events to 130% (52.1 ± 1.6 vs. 67.5 ± 1.9% of cardiomyocytes exhibiting at least one spontaneous contractile event min^−1^; media vs. supernatant; *P* \< 0.001; *Figure [1](#CVT187F1){ref-type="fig"}B*). Separate experiments assessed this effect with reduction of external \[Ca^2+^\]~o~ by equivalent amounts in both media and supernatant. Under these conditions, the supernatant effect was maintained with an increased percentage of cardiomyocytes demonstrating spontaneous contractile events above media levels (17.4 ± 3.2 vs. 34.5 ± 2.5% of cardiomyocytes exhibiting at least one spontaneous contractile event min^−1^; media vs. supernatant; *P* \< 0.05; data not shown). Extracellular \[Ca^2+^\]~o~ and pH were not significantly different between media or supernatant. If supernatant was heated to 80°C prior to incubation, the spontaneous contractile event increase was abolished (data not shown). Figure 1(*A*) Isolated rat cardiomyocyte incubated with *Trypanosoma brucei* (grey arrowheads). (*B*) % cardiomyocytes with spontaneous contractile events (*n* = cardiomyocytes with number of hearts in parentheses). (*C*) Protocol used in separate confocal experiments. (*D*) Upper (i and ii) confocal line-scan images of cardiomyocytes from bracketed region in (*C*). Lower (i and ii) respective line profile trace taken from a 20 pixel region (denoted by yellow lines in upper image). (iii) Mean Ca^2+^ wave frequency; media (*n* = 18) and supernatant (*n* = 21). (*E*i and ii) Individual Ca^2+^ waves, (iii) mean Ca^2+^ wave velocity in media (*n* = 53 waves from 18 cells) and supernatant (*n* = 158 waves from 21 cells).

3.2. Spontaneous contractile events are due to Ca^2+^ waves {#s3b}
-----------------------------------------------------------

Confocal imaging was performed to characterize the cardiomyocyte \[Ca^2+^\]~i~ dynamics underpinning the spontaneous contractile events (*Figure [1](#CVT187F1){ref-type="fig"}C*). The line-scan mode produced images of time (*x*) vs. distance (*y*) across the cardiomyocyte (*Figure [1](#CVT187F1){ref-type="fig"}D*i and ii). Spontaneous contractile events (denoted by an inward deflection in the *y*-axis of the image, *Figure [1](#CVT187F1){ref-type="fig"}E*) were preceded by a fluorescence and therefore \[Ca^2+^\]~i~ rise, which propagated from one region of the cell to another (*Figure [1](#CVT187F1){ref-type="fig"}D*i and ii). These events were characteristic of spontaneous SR-mediated Ca^2+^ release (Ca^2+^ waves). Ca^2+^ wave frequency in cardiomyocytes incubated with supernatant increased to 243% of media levels (0.07 ± 0.02 vs. 0.17 ± 0.03waves s^−1^; media vs. supernatant; *P* \< 0.05; *Figure [1](#CVT187F1){ref-type="fig"}D*iii). Ca^2+^ wave velocity, calculated as the Ca^2+^ wave propagation gradient (*Figure [1](#CVT187F1){ref-type="fig"}E*i and ii), increased in supernatant to 107% of media (110.2 ± 2.2 vs. 118.4 ± 1.7 µm s^−1^; media vs. supernatant; *P* \< 0.05; *Figure [1](#CVT187F1){ref-type="fig"}E*iii).

3.3. Supernatant increases the decay rate constant of the stimulated Ca^2+^ transient {#s3c}
-------------------------------------------------------------------------------------

Cardiomyocytes loaded with Fura-4F were used to determine the electrically stimulated systolic Ca^2+^ transient characteristics without movement artefact (*Figure [2](#CVT187F2){ref-type="fig"}A*). The mean Ca^2+^ transient maximum and minimum ratios were unaltered by supernatant perfusion (data not shown), therefore, resulting in no significant change in Ca^2+^ transient amplitude (106.42% of media; *P* \> 0.05; *Figure [2](#CVT187F2){ref-type="fig"}B*i and ii). Similarly, the Ca^2+^ transient mean maximum rates of rise and fall were unaltered by supernatant (data not shown), although the rate of fall tended to be faster (127.8% of media), albeit not significantly (*P* = 0.09). In contrast, supernatant significantly increased Ca^2+^ transient decay rate constant to 138.6% of media levels (11.3 ± 1.06 vs. 15.68 ± 1.41 s^−1^; media vs. supernatant; *P* \< 0.05; *Figure [2](#CVT187F2){ref-type="fig"}B*iii). Figure 2(*A*) Protocol used in epifluorescence Ca^2+^ measurements. (*B*i) Average trace from last 12 stimulated Ca^2+^ transients in media (*n* = 10; grey) or supernatant (*n* = 14; black); (inset) normalized traces overlayed. (*B*ii) mean Ca^2+^ transient amplitude and (iii) decay rate constant. (*C*) Protocol used in separate epifluorescence experiments. (*D*) Typical trace of \[Ca^2+^\]~i~ during protocol in (*C*). (*D*ii) Ca^2+^ transient parameters and (iii) decay rate constant at low \[Ca^2+^\]~o~ (left panel; *n* = 8) and normal \[Ca^2+^\]~o~ (right panel; *n* = 13). (*E*i) Caffeine-induced Ca^2+^ transient parameters and (ii) decay rate constant at low \[Ca^2+^\]~o~ (left panel) and normal \[Ca^2+^\]~o~ (right panel). (*F*) Fura-2AM ratio during SR inhibition with media (*n* = 10) and supernatant (*n* = 11). (*G*) First Ca^2+^ transient amplitude post-caffeine during protocol C at low \[Ca^2+^\]~o~ (left panel) and normal \[Ca^2+^\]~o~ (right panel).

3.4. Supernatant reduces SR Ca^2+^ content {#s3d}
------------------------------------------

The SR Ca^2+^ content significantly influences Ca^2+^ transient characteristics. The SR Ca^2+^ content was determined by the assessment of the Ca^2+^-induced Ca^2+^ release amplitude, induced by 10 mM caffeine application (20 s) once after perfusion of cardiomyocytes with media and then again after supernatant perfusion in the same cell (*Figure [2](#CVT187F2){ref-type="fig"}C*). This paired protocol permitted accurate determination of small SR Ca^2+^ content changes between media and supernatant. As in *Figure [2](#CVT187F2){ref-type="fig"}B*, the Ca^2+^ transient minimum, maximum, and amplitude between media and supernatant were not significantly different (*Figure [2](#CVT187F2){ref-type="fig"}D*i and ii right panel), yet the Ca^2+^ transient decay rate constant was significantly increased (12.2 ± 1.2 vs. 13.4 ± 1.4 s^−1^; media vs. supernatant; *P* \< 0.05; *Figure [2](#CVT187F2){ref-type="fig"}D*iii right panel). The same results were obtained when Ca^2+^ transient amplitude was reduced by lowering extracellular \[Ca^2+^\]~o~, i.e. no change in Ca^2+^ transient amplitude but an increased decay rate constant induced by supernatant (8.5 ± 0.4 vs. 9.4 ± 0.4 s^−1^; media vs. supernatant; *P* \< 0.05; *Figure [2](#CVT187F2){ref-type="fig"}D*iii left panel). The amplitude of the caffeine-induced Ca^2+^ release was reduced by supernatant at both normal \[Ca^2+^\]~o~ (760.9 ± 42.9 vs. 698.3 ± 39.4 nM; media vs. supernatant; *P* \< 0.05; *Figure [2](#CVT187F2){ref-type="fig"}E*i right panel) and lower \[Ca^2+^\]~o~ (958.7 ± 52.2 vs. 769.4 ± 41.9 nM; media vs. supernatant; *P* \< 0.05; *Figure [2](#CVT187F2){ref-type="fig"}E*i left panel) suggesting that supernatant significantly reduced the SR Ca^2+^ content. In the continued presence of caffeine, the SR cannot re-accumulate Ca^2+^ and removal from the cell is predominantly by sarcolemmal extrusion. The caffeine-induced Ca^2+^ transient time constant of decline was not significantly altered by supernatant at either normal or lower extracellular \[Ca^2+^\]~o~ (*Figure [2](#CVT187F2){ref-type="fig"}E*ii).

3.5. Supernatant increases diastolic \[Ca^2+^\]~i~ via a non-SR dependent route {#s3e}
-------------------------------------------------------------------------------

To assess whether supernatant could alter diastolic \[Ca^2+^\]~i~ in the absence of SR-mediated Ca^2+^ release or uptake, the higher affinity dye Fura-2AM was utilized in cardiomyocytes where SR function was inhibited by thapsigargin and ryanodine (*Figure [2](#CVT187F2){ref-type="fig"}F*). In the absence of SR-mediated Ca^2+^ release, supernatant caused a persistent, significant elevation of diastolic \[Ca^2+^\]~i~ over the 4 min period compared with media (*Figure [2](#CVT187F2){ref-type="fig"}F*). One possible route through which diastolic \[Ca^2+^\]~i~ may have increased was through the L-type Ca^2+^ channel. To assess this possibility, the amplitude of the first Ca^2+^ transient after 10 mM caffeine application (an index of Ca^2+^ influx *via* the L-type Ca^2+^ channel) was measured during media or supernatant perfusion (*Figure [2](#CVT187F2){ref-type="fig"}D*i). No significant difference was detected in the first Ca^2+^ transient amplitude between media and supernatant (*Figure [2](#CVT187F2){ref-type="fig"}G*).

3.6. Alteration of SR function by supernatant is CaMKII dependent {#s3f}
-----------------------------------------------------------------

To examine whether CaMKII or PKA is involved in the supernatant action on SR function, inhibitors were utilized in separate experimental cohorts (as in *Figure [1](#CVT187F1){ref-type="fig"}B*). The increase in spontaneous contractile events was abolished by the CaMKII inhibitor autocamtide-2 related inhibitory peptide (AIP) (to 104% of media + AIP levels; *Figure [3](#CVT187F3){ref-type="fig"}A*i) but not by the PKA inhibitor H89 (N-\[2-(p-bromocinnamylamino)ethyl\]-5-iso-quinolinesulphonamide) (Sigma-Aldrich) (to 129% of media + H89 levels; *Figure [3](#CVT187F3){ref-type="fig"}A*ii). An additional cohort of cells pre-incubated in AIP underwent field stimulation during the same protocol shown in *Figure [2](#CVT187F2){ref-type="fig"}C*. No change in Ca^2+^ transient amplitude was apparent. However, AIP abolished the supernatant-induced Ca^2+^ transient rate decay constant increase and SR Ca^2+^ content decrease (*Figure [3](#CVT187F3){ref-type="fig"}B*). To assess whether the non-SR dependent diastolic \[Ca^2+^\]~i~ elevation was CaMKII-dependent as shown in *Figure [2](#CVT187F2){ref-type="fig"}F*, the same protocol was used but in cardiomyocytes pre-incubated with AIP. The CaMKII inhibitor did not abolish the supernatant-induced diastolic \[Ca^2+^\]~i~ elevation (*Figure [3](#CVT187F3){ref-type="fig"}C*). Figure 3(*A*) % Change in cardiomyocytes with spontaneous contractile events supernatant + AIP (*n* = 307) vs. media + AIP (*n* = 121) or (ii) H89 + supernatant (*n* = 377) vs. media + H89 (*n* = 305). (*B*) % change in Ca^2+^ transient and caffeine-induced parameters with AIP. (*C*) Fura-2AM ratio during SR inhibition + AIP with media (*n* = 25) and supernatant (*n* = 21).

3.7. Supernatant effects on the stimulated Ca^2+^ transient during β-adrenergic stimulation {#s3g}
-------------------------------------------------------------------------------------------

The sympathetic nervous system and β-adrenergic signalling pathway activate in response to physiological and pathophysiological stresses. To examine supernatant effects under β-adrenergic stimulation, isoproterenol was added (ISO,100 nM; *Figure [4](#CVT187F4){ref-type="fig"}A*). Under these conditions, supernatant did not significantly alter the mean maximum \[Ca^2+^\]~i~ or Ca^2+^ transient amplitude, but did increase the minimum \[Ca^2+^\]~i~ between field stimulations to 115% of control levels (0.20 ± 0.010 vs. 0.22 ± 0.006 μM; media vs. supernatant; *P* \< 0.05; *Figure [4](#CVT187F4){ref-type="fig"}B*i--iii, and *C*ii). The maximum rate of rise of the Ca^2+^ transient was not altered by supernatant but supernatant increased the maximum rate of fall to 133% of control levels (16.0 ± 1.7 vs. 21.4 ± 2.0 μM ms^−1^; media vs. supernatant; *P* \< 0.05; *Figure [4](#CVT187F4){ref-type="fig"}C*v). This latter result is confirmed by the significant increase in Ca^2+^ transient decay constant by supernatant to 126% of control values; 16.54 ± 1.34 vs. 20.86 ± 1.31 s^−1^; media vs. supernatant; *P* \< 0.05; *Figure [4](#CVT187F4){ref-type="fig"}C*vi). Figure 4(*A*) Protocol with 100 nM isoproterenol (ISO) (*B*) Typical traces of cells superfused with (i) media(*n* = 13) or (ii) supernatant(*n* = 12); (iii) Average trace from last 12 transients; media(grey), supernatant(black); (inset) normalized traces overlayed. (*C*i--vi) Mean Ca^2+^ transient parameters. (*D*i) Number of diastolic Ca^2+^ releases in supernatant (black) normalized to control (grey); (ii) mean Ca^2+^ wave frequency and (iii) amplitude.

As shown in *Figure [4](#CVT187F4){ref-type="fig"}B*i vs. ii, supernatant increased the appearance of Ca^2+^ waves between stimulated Ca^2+^ transients. Cardiomyocytes superfused with supernatant and ISO demonstrated a Ca^2+^ wave frequency increase over time, plateauing at 90 s; (*Figure [4](#CVT187F4){ref-type="fig"}D*i). The mean Ca^2+^ wave frequency (measured over 90--120 s) increased to 866% of control levels during perfusion with supernatant compared with media (0.03 ± 0.01 vs. 0.26 ± 0.09 Ca^2+^ wave s^−1^; media vs. supernatant; *P* \< 0.05; (*Figure [4](#CVT187F4){ref-type="fig"}D*ii). The Ca^2+^ wave amplitude also increased to 632% of control levels (9.4 ± 6.4 vs. 59.7 ± 21.0 nM \[Ca^2+^\]~i~; media vs. supernatant; *P* \< 0.05; *Figure [4](#CVT187F4){ref-type="fig"}D*iii).

3.8. Ca^2+^ wave increase is abolished by inhibition of parasite cathepsin-L {#s3h}
----------------------------------------------------------------------------

The trypanosome factor associated with BMEC cytosolic Ca^2+^ rises was *T. brucei* cathepsin-L (TbCatL).^[@CVT187C12]^ *Trypanosoma brucei* expresses two Clan CA, Family C1 cysteine proteases; TbCatL and TbCatB.^[@CVT187C15],[@CVT187C16]^ Given these data, cardiomyocytes were incubated with/without TbCatL-specific inhibitor K11777^[@CVT187C12]^ (10 µM) and spontaneous contractile events assessed within 60 s. Supernatant increased the contractile events to 137% of media levels (100.0 vs. 137.5 ± 5.4% cardiomyocytes with contractile events relative to media; media vs. supernatant; *P* \< 0.05; *Figure [5](#CVT187F5){ref-type="fig"}A*). K11777 inhibited this effect (96.8 ± 5.4 vs. 95.8 ± 2.5% cardiomyocytes with contractile events relative to media; media + K11777 vs. supernatant + K11777; *P* \> 0.05; *Figure [5](#CVT187F5){ref-type="fig"}A*). When repeated with CA074 (10 µM; TbCatB-specific inhibitor) the percentage increase of cardiomyocytes producing contractile events was maintained (103.8 ± 4.0 vs. 127.4 ± 6.4% cardiomyocytes with contractile events relative to media; media + CA074 vs. supernatant + CA074; *P* \< 0.001; *Figure [5](#CVT187F5){ref-type="fig"}A*). These data suggest that the increase in spontaneous contractile events (due to Ca^2+^ waves; *Figure [1](#CVT187F1){ref-type="fig"}*) is TbCatL mediated. Figure 5(*A* and *B*) Mean % change in contractile events over media levels in isolated cardiomyocytes (rTbCatL = 2 nM Recombinant *T. brucei* cathepsin-L + 5 μM dithiothreitol; *n* = number of cells from number of hearts). (*C*) Growth curves of biological duplicates (STL349 and STL350) with inducible TbCatL RNAi. (*D*) Relative TbCatL gene expression to the uninduced culture; triplicate cultures for STL 349 (*n* = 3) and STL 350 (*n* = 3). (*E*i) % change in spontaneous contractile events in cardiomyocytes for clone STL349. Media \[*n* = 747 (7)\], supernatant \[*n* = 817 (7)\], uninduced culture \[*n* = 858 (7)\], and induced culture \[*n* = 841 (7)\]; (ii) % change in spontaneous contractile events in cardiomyocytes for clone STL350. Media \[*n* = 1018 (11)\], supernatant \[*n* = 1427(12)\], uninduced culture \[*n* = 1597 (12)\], or induced culture \[*n* = 1564 (12)\].

3.9. Recombinant TbCatL increases Ca^2+^ wave frequency {#s3i}
-------------------------------------------------------

To confirm the importance of TbCatL in increasing Ca^2+^ waves, recombinant TbCatL (rTbCatL, 2.0 nM) was added to the media (*Figure [5](#CVT187F5){ref-type="fig"}B*). Similar to supernatant, rTbCatL significantly increased the contractile events to 113% of media (106.9 ± 3.7 vs. 120.8 ± 7.1% cardiomyocytes with contractile events relative to media; media with vehicle vs. media + rTbCatL; *P* \< 0.05; *Figure [4](#CVT187F4){ref-type="fig"}B*). These results demonstrate that rTbCatL replicates the supernatant effect of cardiomyocyte SR function alteration.

3.10. TbCatL RNA interference abolishes the Ca^2+^ wave increase {#s3j}
----------------------------------------------------------------

Two independent *T. brucei* clones (STL349 and STL350) with inducible RNAi TbCatL knockdown were assessed in cardiomyocyte spontaneous contractile event measurements. TbCatL is necessary for parasite survival.^[@CVT187C17]^ Consequently, RNAi induction inhibited growth after 48 h (*Figure [5](#CVT187F5){ref-type="fig"}C*). Quantitative PCR on cDNA from mRNA extracted at 24 h (i.e. before affected growth) show that RNAi induction reduced TbCatL expression by 85--90% (0.15 ± 0.02 for STL349 and 0.1 ± 0.005 for STL350 relative quantification to uninduced cultures; *P* \< 0.05; *Figure [5](#CVT187F5){ref-type="fig"}D*).

Induced TbCatL RNAi for STL349 significantly reduced the cardiomyocyte percentage producing spontaneous contractile events to media levels, compared with the same clone uninduced (97.0 ± 5.1 vs. 116.2 ± 5.0% cardiomyocytes with contractile events relative to media levels; induced vs. uninduced; *P* \< 0.05; *Figure [5](#CVT187F5){ref-type="fig"}E*i). The same occurred with STL350 (102.0 ± 5.7 vs. 116.5 ± 5.6% cardiomyocytes with contractile events relative to media levels; induced vs. uninduced; *P* \< 0.05; *Figure [5](#CVT187F5){ref-type="fig"}E*ii). In each experiment subset (*Figure [5](#CVT187F5){ref-type="fig"}E*i and ii), supernatant increased spontaneous contractile events to 123% of media levels (100.0 vs. 122.7 ± 5.4% cardiomyocytes with contractile events relative to media levels; media vs. supernatant; *P* \< 0.05). These data show that the supernatant-induced increased Ca^2+^ waves are abolished if TbCatL gene expression is reduced to ∼10% of control levels.

3.11. Supernatant leads to arrhythmic events in whole hearts {#s3k}
------------------------------------------------------------

Given the established link between spontaneous SR-mediated Ca^2+^ release and arrhythmias, the arrhythmogenic potential of supernatant was investigated in *ex vivo* whole hearts. The pseudo-ECG was examined for VPCs (*Figure [6](#CVT187F6){ref-type="fig"}A* and *B*), known to be associated with abnormal diastolic Ca^2+^ release. Each VPC was counted as one arrhythmic event. There was no significant difference in mean arrhythmic frequency between the different time periods of the protocol in the time-control group; (0.40 ± 0.28 vs. 0.33 ± 0.19 vs. 0.53 ± 0.27 VPCs min^−1^; first, second, and third 10 min period, respectively; *P* \> 0.05; *Figure [6](#CVT187F6){ref-type="fig"}C*). However, in hearts perfused with supernatant there was a significant increase in mean arrhythmic event frequency which then reduced during the washout period (0.60 ± 0.26 vs. 5.15 ± 2.49 vs. 1.36 ± 0.73 PCs min^−1^; first, second, and third 10 min period, respectively; *P* \< 0.05 between first and second period; *Figure [6](#CVT187F6){ref-type="fig"}C*). There was no significant difference in heart rate between hearts perfused with media (282 ± 17 b.p.m.) or supernatant (278 ± 12 b.p.m.). Figure 6(*A*) Langendorff perfused heart protocol. (*B*) typical pseudo-ECG recordings. (*C*) Mean number of ventricular premature complexes (VPCs) per min for time control (*n* = 6) and supernatant-perfused hearts (*n* = 12) in media (first 10 min; white bar), switch to media or supernatant (second 10 min; black bar), and media washout (third 10 min; grey bar).

4.. Discussion {#s4}
==============

Using isolated cardiomyocytes and whole hearts, we have demonstrated for the first time that *Trypanosoma brucei* can alter cardiac function without a systemic immune response or autonomic nervous system effect. Prior to this study, the only suggested mechanism for cardiac-related clinical symptoms has been the immune/inflammatory response to the parasite. Our data demonstrate that this is not the sole mechanism and present a new paradigm for trypanosome-induced cardiac dysfunction.

4.1. Alteration of spontaneous SR-mediated Ca^2+^ release in isolated cardiomyocytes {#s4a}
------------------------------------------------------------------------------------

Isolated cardiomyocytes show increased spontaneous contractile activity when exposed to both parasites and supernatant (*Figure [1](#CVT187F1){ref-type="fig"}*). Such spontaneous contractile activity can be associated with spontaneous SR-mediated Ca^2+^ release in the form of Ca^2+^ waves, which was demonstrated in this study (*Figure [1](#CVT187F1){ref-type="fig"}*). A similar effect has been observed in BMECs, where \[Ca^2+^\]~i~ spontaneous releases occurred despite the removal of the parasite from the media.^[@CVT187C12]^ It is clear therefore that in both cardiomyocytes and BMECs, the \[Ca^2+^\]~i~ alteration is mediated by a trypanosome-derived (secreted/excreted) factor.

4.2. Ca^2+^ wave velocity and frequency are increased by supernatant {#s4b}
--------------------------------------------------------------------

Altered Ca^2+^ wave characteristics indicate altered SR function.^[@CVT187C18]^ In this study, two notable effects on Ca^2+^ wave characteristics occurred post-field stimulation. In agreement with spontaneous contractile event measurements (*Figure [1](#CVT187F1){ref-type="fig"}A*), an increased Ca^2+^ wave frequency was observed in cardiomyocytes incubated with supernatant. Ca^2+^ waves are linked to both arrhythmias and contractile dysfunction and increased Ca^2+^ wave frequency is likely to increase whole heart arrhythmias.^[@CVT187C13]^ Ca^2+^ wave frequency is determined by the time taken to reach a SR Ca^2+^ threshold.^[@CVT187C13]^ SERCA stimulation by a direct or indirect effect of a supernatant factor would increase the SR Ca^2+^accumulation rate and hence decrease the time between spontaneous events.^[@CVT187C13],[@CVT187C19]^ O\'Neill *et al.*^[@CVT187C19]^ also showed that Ca^2+^ wave velocity was directly related to SERCA activity, and thus the increased Ca^2+^ wave velocity observed in the current study may be an expected additional effect of enhanced SERCA activity.

4.3. Effects of supernatant on SR function {#s4c}
------------------------------------------

The proposal that exposure to supernatant increases cardiac SERCA activity is consistent with the supernatant effects on the stimulated Ca^2+^ transient (*Figures [2](#CVT187F2){ref-type="fig"}* and *[4](#CVT187F4){ref-type="fig"}*), which showed an increased decay rate constant. SERCA activity (K~SERCA~) was estimated by measuring the rate constant of decay of the electrically stimulated Ca^2+^ transient. However, sarcolemmal efflux from the cell also contributes to this rate constant of decay. When the rate constant of decay of the caffeine-induced Ca^2+^ transient (which includes sarcolemmal efflux but no SR uptake contribution) is subtracted from that of the electrically stimulated Ca^2+^ transient (which includes the combined SR uptake and sarcolemmal efflux)^[@CVT187C20]^ the % change in K~SERCA~ induced by the supernatant was 114.3 ± 2.2% of media control. This compares well with the value (110.4 ± 1.2; *Figure [2](#CVT187F2){ref-type="fig"}D*iii) when using the rate decay constant of the electrically induced transient alone. Therefore, both values are very similar and we conclude that SERCA activity is significantly increased by the supernatant by 10--15%. An alternative explanation for the increased decay time constant is alteration of myofilament Ca^2+^ responsiveness. However, the supernatant had no effect on myofilament sensitivity to \[Ca^2+^\]~i~ ([Supplementary material online](http://cardiovascres.oxfordjournals.org/lookup/suppl/doi:10.1093/cvr/cvt187/-/DC1)). If enhanced SERCA activity was the exclusive action of the supernatant on SR function then the SR Ca^2+^ content may be expected to have increased. However, *Figure [2](#CVT187F2){ref-type="fig"}* clearly shows that the supernatant decreases the SR Ca^2+^ content. This decrease cannot be explained by increased sarcolemmal efflux, as the caffeine-induced Ca^2+^ transient decay rate constant and diastolic \[Ca^2+^\]~i~ were unaltered. Therefore, we hypothesize that in addition to mild (10--15%) stimulation of SERCA activity, TbCatL also enhances SR-mediated Ca^2+^ leak; the net effect being reduction in the SR Ca^2+^ content. An increased SR-mediated Ca^2+^ leak could potentially occur via the ryanodine receptor (RyR). A large body of work has confirmed that increased RyR open probability may lead to: (i) unaltered stimulated Ca^2+^ transient amplitude, (ii) reduction in the SR Ca^2+^ content, (iii) increased Ca^2+^ wave frequency in resting cells, and (iv) sustained and increased Ca^2+^ waves during electrical stimulation in the presence of β-adrenergic stimulation (reviewed in^[@CVT187C13]^). The data presented demonstrate the above features and therefore support the hypothesis that TbCatL induces SR-mediated Ca^2+^ leak with parallel SERCA activity increase. CaMKII (but not PKA) inhibition abolished the supernatant effect on SR Ca^2+^ uptake and content. Importantly, this in turn led to the abolishment of the expected increased in Ca^2+^ waves (*Figure [3](#CVT187F3){ref-type="fig"}*). Enhanced SR Ca^2+^ leak and a subsequent reduction of SR Ca^2+^ content can be prevented by AIP in cardiomyocytes overexpressing CaMKII without significantly altering the Ca^2+^ transient amplitude.^[@CVT187C21]^ Furthermore, SR-localized AIP can also inhibit CaMKII-dependent regulation of SERCA-mediated Ca^2+^ uptake.^[@CVT187C22]^ Therefore, these data support the proposed mechanism of a parallel effect of the supernatant on abnormal SR Ca^2+^ release and uptake that leads to the increased Ca^2+^ wave frequency observed.

4.4. Effects of supernatant on diastolic \[Ca^2+^\]~i~ {#s4d}
------------------------------------------------------

Isolated cardiomyocyte experiments where SR-mediated Ca^2+^ release and uptake was inhibited (*Figure [2](#CVT187F2){ref-type="fig"}F*) revealed that supernatant elevated \[Ca^2+^\]~i~ compared with control media. Our experiments do not discriminate between reduced Ca^2+^ efflux or enhanced Ca^2+^ influx, but increased diastolic \[Ca^2+^\]~i~ may favour the production of abnormal SR Ca^2+^ release. One potential mechanism for increased diastolic \[Ca^2+^\]~i~ is reduced NCX activity, the main sarcolemmal Ca^2+^ extrusion process. However, Ca^2+^ extrusion rate in the presence of caffeine was unaltered by supernatant (*Figure [2](#CVT187F2){ref-type="fig"}*), suggesting NCX activity was unaffected. Alternatively, supernatant may have enhanced Ca^2+^ entry into cardiomyocytes, but in quiescent cells this is unlikely to be via the L-type Ca^2+^ channel (see *Figure [2](#CVT187F2){ref-type="fig"}G*). Interestingly, this effect was not AIP-sensitive (*Figure [3](#CVT187F3){ref-type="fig"}*). The changes in basal and store-based Ca^2+^ signalling observed in cardiomyocytes parallel those seen in BMECs,^[@CVT187C12]^ an effect mediated by TbCatL action on a GPCR mediated pathway.^[@CVT187C23]^ Activation of this or a similar pathway in cardiomyocytes may underlie the supernatant effect on the heart. Overall, it is possible that supernatant elevates diastolic \[Ca^2+^\]~i~ (which could be substantial within subcellular compartments) causing CaMKII activation, which then increases SR-mediated Ca^2+^ leak and uptake with a net effect being an increase in Ca^2+^ waves and reduced SR Ca^2+^.

4.5. Ca^2+^ waves are caused by TbCatL {#s4e}
--------------------------------------

The cathepsin-L inhibitor K11777 prevented the supernatant-mediated increase in Ca^2+^ waves. This demonstrated for the first time that TbCatL increases spontaneous Ca^2+^ release from the cardiomyocyte SR. These results are consistent with rTbCatL increasing Ca^2+^ waves (gain of function) and RNAi reducing TbCatL gene expression and decreasing Ca^2+^ waves (loss of function). The combined pharmacological, recombinant protein, and RNAi approaches confirmed that trypanosome-produced extracellular TbCatL causes the increased arrhythmogenic SR-mediated Ca^2+^ release in adult rat ventricular cardiomyocytes, independent of an immune/inflammatory response. TbCatL is essential to parasite survival (hence RNAi use rather than gene knockout, which is lethal).^[@CVT187C17]^ Current HAT drugs are difficult to administer in the field and cause severe toxic side effects in 5--10% of cases (average case-fatality rate of 50%).^[@CVT187C24]^ Cysteine protease peptide inhibitors are currently being tested as novel trypanocides.^[@CVT187C17]^ Our study suggests that in addition to being trypanocidal, drugs that target TbCatL may limit both BBB pathology and cardiac dysfunction.

4.6. Supernatant causes arrhythmic events in whole hearts {#s4f}
---------------------------------------------------------

Field studies report a range of ECG abnormalities and palpitations in HAT patients that can result from VPCs.^[@CVT187C2]^ The link is established between Ca^2+^ waves, delayed after-depolarization and subsequent VPC production in the whole heart which may induce fatal arrhythmias (reviewed in^[@CVT187C13]^). Supernatant is able to increase VPCs independent of an immune response under β-adrenergic stimulation conditions. This is the first time that trypanosomes have been shown to contribute directly to whole heart arrhythmias. It is unclear to what degree HAT patients under stress (e.g. exercise/pathological states) would have an increased arrhythmia risk, but from our findings we hypothesize that HAT patients would be more prone to arrhythmic events under stress conditions. Indeed, there are reports of sudden death in HAT patients before full progression of the disease, and in these cases sudden arrhythmic-induced cardiac death cannot be ruled out.^[@CVT187C5],[@CVT187C6]^

4.7. Study implications and conclusions {#s4g}
---------------------------------------

Extracellular cathepsin-L not only disrupts Ca^2+^ release from intracellular stores in the brain but as we have shown for the first time, also in the heart. This common pathogenic mechanism provides a platform to support future investigations that centre on normalization of the effects of cathepsin-L via drugs that act on SR/ER-mediated Ca^2+^ signalling in order to address the neurological and cardiovascular pathology associated with HAT. Previous studies have shown that arrhythmias associated with disrupted SR function can be treated with flecainide and K201(JTV-519)^[@CVT187C14]^ and this suggests a potential therapeutic approach for treatment of cathepsin-L induced cardiac dysfunction.

The findings of this study also have implications for other pathogens, such as *Trypanosoma cruzi,* which causes Chagas disease. Notable cardiac pathology is present in Chagas disease, and *T. cruzi* induces abnormal Ca^2+^ handling in cardiomyocytes.^[@CVT187C25]^ Another important implication concerns coronary heart disease (CHD). It is well established that patients with CHD have abnormal SR-mediated Ca^2+^ release, contractile dysfunction, increased arrhythmia risk, and elevated levels of endogenous cathepsin-L in serum, yet the effect of mammalian-derived extracellular cathepsins on SR function remains unknown.
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